The HLA class III subregion is responsible for an increased breast cancer risk

Human Molecular Genetics

Volumn 12, Issue 18, 2003, Pages 2311-2319

  de Jong, Mirjam M ^a   Nolte, Ilja M ^a   de Vries, Elisabeth G E ^a   Schaapveld, Michael ^b   Kleibeuker, Jan H ^a   Oosterom, Elvira ^a   Oosterwijk, Jan C ^a   van der Hout, Annemarie H ^a   van der Steege, Gerrit ^a   Bruinenberg, Marcel ^a   Boezen, H Marike ^a   te Meerman, Gerard J ^a   van der Graaf, Winette T A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Integraal Kankercentrum Noord Nederland   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN CLASS 3; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; FAMILY HISTORY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GERM LINE; HAPLOTYPE; HETEROZYGOSITY; HIGH RISK PATIENT; HOMOZYGOSITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; PRIORITY JOURNAL; RECESSIVE INHERITANCE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HAPLOTYPES; HLA ANTIGENS; HOMOZYGOTE; HUMANS; LINKAGE DISEQUILIBRIUM; MICROSATELLITE REPEATS; MIDDLE AGED; NETHERLANDS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 10744231724     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg245     Document Type: Article

References (37)

1. Aubele, M. and Werner, M. (1999) Heterogeneity in breast cancer and the problem of relevance of findings. Anal. Cell Pathol., 19, 53-58.
2. Phelan, C.M., Lancaster, J.M., Tonin, P., Gumbs, C., Cochran, C., Carter, R., Ghadirian, P., Perret, C., Moslehi, R., Dion, F. et al. (1996) Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat. Genet., 13, 120-122.
3. Easton, D. (1997) Breast cancer genes - what are the real risks? Nat. Genet., 16, 210-211.
4. Meijers-Heijboer, H., van den Ouweland, A., Klijn, J., Wasielewski, M., de Snoo, A., Oldenburg, R., Hollestelle, A., Houben, M., Crepin, E., van Veghel-Plandsoen, M. et al. (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat. Genet., 31, 55-59.
5. Easton, D.F. (1999) How many more breast cancer predisposition genes are there? Breast Cancer Res., 1, 14-17.
6. Cui, J., Antoniou, A.C., Dite, G.S., Southey, M.C., Venter, D.J., Easton, D.F., Giles, G.G., McCredie, M.R. and Hopper, J.L. (2001) After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer. Am. J. Hum. Genet., 68, 420-431.
7. Antoniou, A.C., Pharoah, P.D., McMullan, G., Day, N.E., Ponder, B.A. and Easton, D. (2001) Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet. Epidemiol., 21, 1-18.
8. Antoniou, A.C., Pharoah, P.D., McMullan, G., Day, N.E., Stratton, M.R., Peto, J., Ponder, B.J. and Easton, D.F. (2002) A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br. J. Cancer, 86, 76-83.
9. Rebbeck, T.R. (1999) Inherited genetic predisposition in breast cancer. A population-based perspective. Cancer, 86, 2493-2501.
10. te Meerman, G.J. and de Vries, E.G.E. (2001) Relevance of high and low penetrance. Lancet, 358, 331-332.
11. de Jong, M.M., Nolte, I.M., te Meerman, G.J., van der Graaf W.T., Oosterwijk, J.C., Kleibeuker, J.H., Schaapveld, M. and de Vries, E.G. (2002) Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J. Med. Genet., 39, 225-242.
12. Tsujimura, A., Ota, M., Katsuyama, Y., Sada, M., Miura, H., Matsumiya, K., Gotoh, R., Nakatani, T., Okuyama, A. and Takahara, S. (2002) Susceptibility gene for non-obstructive azoospermia located near HLA-DR and -DQ loci in the HLA class II region. Hum. Genet., 110, 192-197.
13. Bouillenne, C. and Deneufbourg, J.M. (1979) Positive correlation between breast cancer incidence and HLA antigens. Oncology, 36, 156-159.
14. Hammond, M.G., Appadoo, B. and Brain, P. (1979) HLA and cancer in South African indians. Tissue Antigens, 14, 296-302.
15. Subira, M.L., Crisci, C.D., Zornoza, G., Sanz, M.L., Voltas, J., Hernandez, J.L. and Oehling, A. (1979) Breast cancer and histocompatibility antigens. Allergol. Immunopathol. (Madr.), 7, 411-416.
16. Abrahamova, J. and Majsky, A. (1988) HLA system and some neoplastic diseases. Acta Univ. Carol. Med. Monogr., 123, 1-80.
17. Biswal, B.M., Kumar, R., Julka, P.K., Sharma, U. and Vaidya, M.C. (1998) Human leucocytic antigens (HLA) in breast cancer. Ind. J. Med. Sci., 52, 177-183.
18. Casoli, C., Zanelli, P., Adorni, A., Starcich, B.R. and Neri, T. (1994) Serological and molecular study on the HLA phenotype of female breast cancer patients. Eur. J. Cancer, 30A, 1207-1208.
19. Chaudhuri, S., Cariappa, A., Tang, M., Bell, D., Haber, D.A., Isselbacher, K.J., Finkelstein, D., Forcione, D. and Pillai, S. (2000) Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles. Proc. Natl Acad. Sci. USA, 97, 11451-11454.
20. Ghaderi, A., Talei, A., Gharesi-Fard, B., Fatjadian, S.H., Amirzargar, A. and Vasei, M. (2001) HLA-DBR 1 alleles and the susceptibility of Iranian patients with breast cancer. Pathol. Oncol. Res., 7, 39-41.
21. Mestiri, S., Bouaouina, N., Ahmed, S.B., Khedhaier, A., Jrad, B.B., Remadi, S. and Chouchane, L. (2001) Genetic variation in the tumor necrosis factor-alpha promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma. Cancer, 91, 672-678.
22. Park, K.S., Mok, J.W., Ko, H.E., Tokunaga, K. and Lee, M.H. (2002) Polymorphisms of tumour necrosis factors A and B in breast cancer. Eur. J. Immunogenet., 29, 7-10.
23. Evans, D.G., Fentiman, I.S., McPherson, K., Asbury, D., Ponder, B.A. and Howell, A. (1994) Familial breast cancer. Br. Med. J., 308, 183-187.
24. Pharoah, P.D., Day, N.E., Duffy, S., Easton, D.F. and Ponder, B.A. (1997) Family history and the risk of breast cancer: a systematic review and meta-analysis. Int. J. Cancer, 71, 800-809.
25. Ford, D., Easton, D.F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D.T., Weber, B., Lenoir, G., Chang, C.J. et al. (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am. J. Hum. Genet., 62, 676-689.
26. Peto, J., Collins, N., Barfoot, R., Seal, S., Warren, W., Rahman, N., Easton, D.F., Evans, C., Deacon, J. and Stratton, M.R. (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J. Natl Cancer Inst., 91, 943-949.
27. Nathanson, K.L. and Weber, B.L. (2001) 'Other' breast cancer susceptibility genes: searching for more holy grail. Hum. Mol. Genet., 10, 715-720.
28. Beckmann, L., Fischer, C., Deck, K.G., Nolte, I.M., te Meerman, G.J. and Chang-Claude, J. (2001) Exploring haplotype sharing methods in general and isolated populations to detect gene(s) of a complex genetic trait. Genet. Epidemiol., 21 (Suppl. 1), S554-S559.
29. Levinson, D.F., Kirby, A., Slepner, S., Nolte, I., Spijker, G.T. and te Meerman, G.J. (2001) Simulation studies of detection of a complex disease in a partially isolated population. Am. J. Med. Genet., 105, 65-70.
30. Rahman, N., and Stratton, M.R. (1998) The genetics of breast cancer susceptibility. A. Rev. Genet., 32, 95-121.
31. Hopper, J.L., Southey, M.C., Dite, G.S., Jolley, D.J., Giles, G.G., McCredie, M.R., Easton, D.F. and Venter, D.J. (1999) Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Cancer Epidemiol. Biomarkers Prev., 8, 741-747.
32. Anglian Breast Cancer Study Group (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br. J. Cancer, 83, 1301-1308.
33. Vahteristo, P., Bartkova, J., Eerola, H., Syrjakoski, K., Ojala, S., Kilpivaara, O., Tamminen, A., Kononen, J., Aittomaki, K., Heikkila, P. et al. (2002) A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am. J. Hum. Genet., 71, 432-438.
34. Pritchard, J.K. and Cox, N.J. (2002) The allelic architecture of human disease genes: common disease-common variant ... or not? Hum. Mol. Genet., 11, 2417-2423.
35. The MHC Sequencing Consortium (1999) Complete sequence and gene map of a human major histocompatibility complex. Nature, 401, 921-923.
36. Boon, M., Nolte, I.M., Bruinenberg, M., Spijker, G.T., Terpstra, P., Raelson, J., De Keyser, J., Zwanikken, C.P., Hulsbeek, M., Hofstra, R.M., Buys, C.H. and te Meerman, G.J. (2001) Mapping of a susceptibility gene for multiple sclerosis to the 51 kb interval between G511525 and D6S1666 using a new method of haplotype sharing analysis. Neurogenetics, 3, 221-230.
37. Lewontin, R.C. (1964) The interaction of selection and linkage. I. General considerations; heterotic models. Genetics, 49, 49-67.